comparemela.com

Latest Breaking News On - இந்தியா பிரைவேட் - Page 10 : comparemela.com

The Q India Appoints Simran Hoon as CEO

The Q India Appoints Simran Hoon as CEO News provided by Share this article Share this article Ad Sales Veteran Brings Two Decades of Experience Delivering Millions in Revenue Growth For India s Top Media Brands  MUMBAI, India and TORONTO, April 28, 2021 /PRNewswire/ - Curt Marvis, CEO and Co-Founder of QYOU Media Inc.  (TSXV: QYOU) (OTCQB: QYOUF) has announced that The Q India, the company s Hindi language youth oriented channel available in over 100 million TV households and to over 612 million OTT and mobile users in India, has appointed Ms. Simran Hoon as the inaugural Chief Executive Officer of QYOU Media s subsidiary The Q India.  Ms. Hoon, who will be Mumbai based, has held leadership roles in advertising sales for over two decades driving massive and sustained revenue growth for major media companies including Viacom, Zee, Disney/Star and Sony.  In addition, throughout  her distinguished career she has gained recognition for out-of-the-box campaigns that h

US President Biden needs to help India now - The Hindu BusinessLine

Covid-19: US President Biden needs to help India now Joe Biden, President, USA   -  AP× RELATED US should share doses from its own supply of Oxford-AstraZeneca, J&J vaccines India has become the terrifying new epicentre of the Covid-19 pandemic. New cases have topped 300,000 daily and are still rising; the official death toll of over 2,000 per day is almost certainly an underestimate. Every hour brings horrifying new stories of mass cremations, overwhelmed testing centres, people dying while waiting for a hospital bed. The country desperately needs help and the United States (US) should provide it. To this point, the Biden administration has rebuffed pleas to share the huge US supply of vaccine doses with the rest of the world, making a slight exception only for neighbors Mexico and Canada. And India is hardly the only nation buffeted by a new wave of cases. Brazil’s official death toll is far higher. Many African countries are struggling to procure vaccines, whereas Ind

Malaria Vaccine Phase 2b Clinical Trial Results Published in Preprints with The Lancet

Published: Apr 23, 2021 Vaccine candidate demonstrates high efficacy at 77% in a study of children aged 5-17 months conducted in Africa Novavax Matrix-M™ adjuvant used in combination with University of Oxford malaria vaccine candidate, R21, and developed in collaboration with Serum Institute of India Phase 3 clinical trial to evaluate safety and efficacy begun in 4,800 participants aged 5-36 months GAITHERSBURG, Md., April 23, 2021 /PRNewswire/ Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the pre-print publication of data from a Phase 2b clinical trial in children demonstrating 77 percent efficacy for a malaria vaccine candidate, R21, created by the University of Oxford that includes Novavax Matrix-M™ adjuvant and is licensed to Serum Institute of India (SII). Published online in

Malaria Vaccine Phase 2b Clinical Trial Results Published in Preprints with The Lancet

Malaria Vaccine Phase 2b Clinical Trial Results Published in Preprints with The Lancet
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Malaria Vaccine Phase 2b Clinical Trial Results Published in Preprints with The Lancet

Malaria Vaccine Phase 2b Clinical Trial Results Published in Preprints with The Lancet
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.